About
Treatments for Inflammatory diseases
Areas of Focus
Categories
Small Molecule PharmaceuticalNJ, NY, PA
Clinical Trials (11)
View allTotal Trials
11
As Lead Sponsor
8
As Collaborator
3
Total Enrollment
1,095
By Phase
PHASE2: 6PHASE2/PHASE3: 1PHASE1/PHASE2: 1PHASE1: 3
By Status
COMPLETED: 5RECRUITING: 3TERMINATED: 2NOT_YET_RECRUITING: 1
Clinical Trials Pipeline11 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
Today
Hover over trial bars to see details
Recent Trials
NCT07157735Collaborator
A Trial to Test the Use of Dapansutrile, an Anti-inflammatory Medication, in People With Parkinson's Disease
PHASE2Not yet recruiting
36 participants
Started: Nov 30, 2025 · Completed: Feb 29, 2028
NCT06047262Collaborator
Dapansutrile in Diabetes and Diabetes-Related Complications - Dapan-Dia
PHASE2Recruiting
300 participants
Started: Jul 9, 2024 · Completed: Jul 31, 2026
NCT05658575Lead Sponsor
Study of Dapansutrile Tablets in Subjects With an Acute Gout Flare
PHASE2/PHASE3Recruiting
300 participants
Started: Jan 6, 2023 · Completed: Dec 31, 2025
NCT04971499Collaborator
A Study of Dapansutrile Plus Pembrolizumab in Patients With PD-1 Refractory Advanced Melanoma
PHASE1/PHASE2Recruiting
26 participants
Started: Sep 6, 2022 · Completed: Apr 30, 2026
NCT04540120Lead Sponsor
Safety and Efficacy of Dapansutrile for Treatment of Moderate COVID-19 Symptoms and Evidence of Early Cytokine Release Syndrome
PHASE2Terminated
49 participants
Started: Sep 24, 2020 · Completed: Jul 28, 2022
Locations (1)
Headquarters
New York, NY, United States
Map
Loading map...